2024 Global aHUS Poll Launches
2024 survey launched to explore atypical HUS patient experiences around the world.
Life and works of Prof. Conrad von Gasser
The Life and works of Prof. Conrad von Gasser continues the series of Before aHUS Endeavours Fade. Contents Introduction Early…
What’s New in aHUS Research – June 2024
As sometimes happens in life, things can arise as a group that makes people take a bit more notice than if…
A website with an all angles approach to aHUS
Some time back aHUS Global Action gave a presentation to an aHUS patient conference and included the following slide about its…
The KDIGO “aHUS” Guidelines have arrived
The long anticipated KDIGO Guidelines from the Controversies Conference held in Florence in September 2022 are now published. The report can…
Atypical HUS & Travel
Atypical HUS & Travel: Planning a trip for work or pleasure? A look at minimizing risks while maximizing a smooth travel adventure.
An aHUS Game Changer
A new blood test for aHUS could be a game changer for those who have been diagnosed with aHUS only to…
An eculizumab biosimilar for the USA
Global Action has received this notice from the FDA. We cannot find a price or evidence from an aHUS trial as…
An eculizumab biosimilar for USA
Global Action has received this notice from the FDA. Cannot find a price or evidence from an aHUS trial as yet.…
- Go to the previous page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- …
- 83
- Go to the next page